'All-inside' meniscal repair shows good long-term outcomes
A second-generation "all-inside" meniscal repair system provides a high success rate at long-term follow-up, reports a study in theJournal of Bone & Joint Surgery.
Jun 21, 2023
0
2
A second-generation "all-inside" meniscal repair system provides a high success rate at long-term follow-up, reports a study in theJournal of Bone & Joint Surgery.
Jun 21, 2023
0
2
In a new paper published today in Nature, researchers at the Francis Crick Institute have outlined the structure and function of a protein complex that is required to repair damaged DNA and protect against cancer.
Jun 21, 2023
0
135
A new research paper titled "Key elements of cellular senescence involve transcriptional repression of mitotic and DNA repair genes through the p53-p16/RB-E2F-DREAM complex" has been published in Aging.
Jun 13, 2023
0
2
A new research paper titled "LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair" has been published in Oncotarget.
Jun 12, 2023
0
27
Researchers from Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University of Lodz have found a way to detect increased cancer risk associated with BRCA1 and BRCA2 mutations without genetic sequencing, ...
Jun 8, 2023
0
62
Repairing or replacing injured tendons or similar load-bearing tissues represents one of the major challenges in clinical medicine. Natural tendons are water-rich tissues exhibiting outstanding mechanical strength and durability. ...
Apr 22, 2023
0
45
Amblyopia, sometimes called lazy eye, is a common vision problem in children and babies, and it's typically been treated by having the child wear a patch on the stronger eye, with the goal of improving sight for the weaker ...
Apr 18, 2023
0
61
Researchers have created the largest atlas of post-zygotic genome mutations in healthy human tissue ever assembled—a scientific advancement that could unlock new avenues for diagnosing and treating genetic disease. It is ...
Apr 13, 2023
0
61
Olaparib (Lynparza), a targeted cancer drug, has been approved for hundreds of patients with certain breast cancers and prostate cancers in England.
Apr 11, 2023
0
22
In a study published in the March 27, 2023, online edition of the New England Journal of Medicine, researchers at the University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health found ...
Mar 27, 2023
0
41